107 related articles for article (PubMed ID: 31442953)
1. Influence of the selenium level on overall survival in lung cancer.
Pietrzak S; Wójcik J; Scott RJ; Kashyap A; Grodzki T; Baszuk P; Bielewicz M; Marciniak W; Wójcik N; Dębniak T; Masojć B; Pieróg J; Cybulski C; Gronwald J; Wojtyś M; Kubisa B; Sukiennicki G; Deptuła J; Waloszczyk P; Jakubowska A; Lubiński J; Lener MR
J Trace Elem Med Biol; 2019 Dec; 56():46-51. PubMed ID: 31442953
[TBL] [Abstract][Full Text] [Related]
2. Serum selenium levels and the risk of progression of laryngeal cancer.
Lubiński J; Marciniak W; Muszynska M; Jaworowska E; Sulikowski M; Jakubowska A; Kaczmarek K; Sukiennicki G; Falco M; Baszuk P; Mojsiewicz M; Kotsopoulos J; Sun P; Narod SA; Lubiński JA
PLoS One; 2018; 13(1):e0184873. PubMed ID: 29304040
[TBL] [Abstract][Full Text] [Related]
3. Serum selenium levels predict survival after breast cancer.
Lubinski J; Marciniak W; Muszynska M; Huzarski T; Gronwald J; Cybulski C; Jakubowska A; Debniak T; Falco M; Kladny J; Kotsopoulos J; Sun P; Narod SA
Breast Cancer Res Treat; 2018 Jan; 167(2):591-598. PubMed ID: 29043463
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of serum microelement concentrations in lung cancer and matched non-cancer patients to determine the risk of developing lung cancer: a preliminary study.
Tominaga K; Saito Y; Mori K; Miyazawa N; Yokoi K; Koyama Y; Shimamura K; Imura J; Nagai M
Jpn J Clin Oncol; 1992 Apr; 22(2):96-101. PubMed ID: 1619784
[TBL] [Abstract][Full Text] [Related]
5. Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study.
Suadicani P; Hein HO; Gyntelberg F
Eur Respir J; 2012 Jun; 39(6):1443-8. PubMed ID: 22034648
[TBL] [Abstract][Full Text] [Related]
6. Serum estrogen receptor beta mediated bioactivity correlates with poor outcome in lung cancer patients.
Lim VW; Lim WY; Zhang Z; Li J; Gong Y; Seow A; Yong EL
Lung Cancer; 2014 Aug; 85(2):293-8. PubMed ID: 24951317
[TBL] [Abstract][Full Text] [Related]
7. Is low selenium status a risk factor for lung cancer?
Knekt P; Marniemi J; Teppo L; Heliövaara M; Aromaa A
Am J Epidemiol; 1998 Nov; 148(10):975-82. PubMed ID: 9829869
[TBL] [Abstract][Full Text] [Related]
8. A low selenium level is associated with lung and laryngeal cancers.
Jaworska K; Gupta S; Durda K; Muszyńska M; Sukiennicki G; Jaworowska E; Grodzki T; Sulikowski M; Waloszczyk P; Wójcik J; Lubiński J; Cybulski C; Dębniak T; Lener M; Morawski AW; Krzystolik K; Narod SA; Sun P; Lubiński J; Jakubowska A
PLoS One; 2013; 8(3):e59051. PubMed ID: 23516596
[TBL] [Abstract][Full Text] [Related]
9. Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer.
Lener MR; Scott RJ; Wiechowska-Kozłowska A; Serrano-Fernández P; Baszuk P; Jaworska-Bieniek K; Sukiennicki G; Marciniak W; Muszyńska M; Kładny J; Gromowski T; Kaczmarek K; Jakubowska A; Lubiński J
Cancer Res Treat; 2016 Jul; 48(3):1056-64. PubMed ID: 26727715
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the correlation of blood selenium and lung cancer. II. An analysis of serum selenium levels and influencing factors in patients with lung cancer].
Hu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):346-9. PubMed ID: 8156579
[TBL] [Abstract][Full Text] [Related]
11. Serum Selenium Level Predicts 10-Year Survival after Breast Cancer.
Szwiec M; Marciniak W; Derkacz R; Huzarski T; Gronwald J; Cybulski C; Dębniak T; Jakubowska A; Lener M; Falco M; Kładny J; Baszuk P; Duszyński J; Kotsopoulos J; Narod SA; Lubiński J
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809461
[TBL] [Abstract][Full Text] [Related]
12. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.
Reid ME; Duffield-Lillico AJ; Garland L; Turnbull BW; Clark LC; Marshall JR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1285-91. PubMed ID: 12433704
[TBL] [Abstract][Full Text] [Related]
13. Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study.
Zakaria HM; Basheer A; Boyce-Fappiano D; Elibe E; Schultz L; Lee I; Siddiqui F; Griffith B; Chang V
Neurosurg Focus; 2016 Aug; 41(2):E12. PubMed ID: 27476836
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.
Tamiya M; Kobayashi M; Morimura O; Yasue T; Nakasuji T; Satomu M; Kohei O; Takayuki S; Morishita N; Suzuki H; Sasada S; Okamoto N; Hirashima T; Kawase I
Clin Lung Cancer; 2013 Jan; 14(1):50-4. PubMed ID: 22609050
[TBL] [Abstract][Full Text] [Related]
15. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk.
Goodman GE; Schaffer S; Bankson DD; Hughes MP; Omenn GS;
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1069-76. PubMed ID: 11588133
[TBL] [Abstract][Full Text] [Related]
16. [Study of relationship between level of serum selenium and syndrome differentiation and typing of traditional Chinese medicine in lung cancer].
Mi YY; Hu YJ; Zhou MZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Nov; 15(11):658-60. PubMed ID: 8732150
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
[TBL] [Abstract][Full Text] [Related]
18. A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patients.
Oyama T; Kawamoto T; Matsuno K; Osaki T; Matsumoto A; Isse T; Nakata S; Ozaki S; Sugaya M; Yasuda M; Yamashita T; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2003; 23(1B):605-12. PubMed ID: 12680155
[TBL] [Abstract][Full Text] [Related]
19. Selenium is inversely associated with bladder cancer risk: a report from the Belgian case-control study on bladder cancer.
Kellen E; Zeegers M; Buntinx F
Int J Urol; 2006 Sep; 13(9):1180-4. PubMed ID: 16984549
[TBL] [Abstract][Full Text] [Related]
20. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
Last KW; Cornelius V; Delves T; Sieniawska C; Fitzgibbon J; Norton A; Amess J; Wilson A; Rohatiner AZ; Lister TA
J Clin Oncol; 2003 Jun; 21(12):2335-41. PubMed ID: 12805335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
